Global Cord Blood Profit Margin

The latest profit margin for CO is 38.59% as of July 2022. That compares with 42.9% in the prior-year period — down 10.0% year over year. That is above the Healthcare sector average of 15.58%. Investors often review this figure alongside Global Cord Blood's historical trend and sector peers before judging valuation or financial health.

Over the past year, CO's profit margin moved from 42.9% to 38.59% — a 10.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Global Cord Blood's valuation or profitability profile.

Against Healthcare companies, CO currently prints 38.59% for profit margin, while the sector average sits near 15.58%. That is roughly 147.6% above the sector mean. Large gaps often invite a closer look at Global Cord Blood's growth, margins, and balance sheet.

Profit Margin shows how effectively Global Cord Blood converts resources into returns. At 38.59%, CO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 42.9% in the prior-year period — down 10.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CO's profit margin (38.59%), review year-over-year change from 42.9%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.